Lilly's 'Triple G' Retatrutide Hits 27% Weight Loss: The End of Bariatric Surgery?
It’s not just another Ozempic. Eli Lilly’s Retatrutide uses a 'Triple G' mechanism to achieve 27% weight loss—rivaling bariatric surgery. Here is the science behind the new king of weight loss.